Stay updated with breaking news from Johnl Bishop. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have issued a buy recommendation on the company. […]
Champlain Investment Partners LLC cut its position in Veracyte, Inc. (NASDAQ:VCYT – Free Report) by 1.9% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 1,918,730 shares of the biotechnology company’s stock after selling 37,100 shares during the period. Champlain Investment Partners LLC’s holdings in Veracyte were worth $42,788,000 as of its most recent […]
Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to the company. The […]
StockNews.com assumed coverage on shares of Veracyte (NASDAQ:VCYT – Free Report) in a research report report published on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. A number of other equities analysts also recently issued reports on the company. Needham & Company LLC increased their price target on Veracyte from […]
StockNews.com began coverage on shares of Veracyte (NASDAQ:VCYT – Free Report) in a research note issued to investors on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. VCYT has been the subject of several other research reports. Needham & Company LLC boosted their price target on Veracyte from $34.00 to $35.00 […]